von Willebrand factor–Glycoprotein Ib axis (VWF-GPIb axis)

The von Willebrand factor–Glycoprotein Ib (VWF-GPIb) axis is a fundamental mechanism for platelet adhesion and thrombus formation, particularly under high-shear conditions found in arteries and stenosed vessels (PubMed: 29433110). This axis is defined by the binding of the A1 domain of multimeric VWF to the N-terminal domain of the GPIbα subunit within the platelet's GPIb-IX-V receptor complex. Upon vascular injury or exposure to high shear stress, VWF undergoes a conformational transition from a globular to an elongated form, exposing the A1 domain for platelet capture (StatPearls, 2023). This interaction initiates platelet 'rolling' and subsequent activation, serving as a prerequisite for stable thrombus formation.\n\nPathologically, an overactive VWF-GPIb axis, often due to a deficiency in the VWF-cleaving protease ADAMTS13, leads to microvascular thrombosis as seen in thrombotic thrombocytopenic purpura (TTP) (NEJM, 2019). Therapeutic agents like caplacizumab, a bivalent nanobody, target this axis by binding the VWF A1 domain, thereby preventing the formation of platelet-rich microthrombi. This approach provides a targeted antithrombotic strategy that specifically addresses shear-dependent platelet aggregation, which is distinct from the mechanisms of traditional antiplatelet drugs like aspirin or P2Y12 inhibitors.

Other names

VWF-GPIbα interactionVWF-GPIb-IX-V complexPlatelet GPIb-VWF axisGPIb-VWF interactionVWF-GPIb axis

Inhibition of the interaction between the A1 domain of von Willebrand factor (VWF) and the Glycoprotein Ib alpha (GPIbα) subunit of the platelet GPIb-IX-V complex, preventing platelet tethering and adhesion under high shear stress (PubMed: 31063728).